Analysis of the Anticoagulant Market

News provided by

Feb 07, 2012, 05:48 ET

NEW YORK, Feb. 7, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Analysis of the Anticoagulant Market

http://www.reportlinker.com/p0760991/Analysis-of-the-Anticoagulant-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

The U.S. anticoagulant market is on the verge of a potential major shift in clinical practice, from a market dominated by a single injectable anticoagulant to a highly competitive market dominated by first-in-class novel oral anticoagulants. While these novel oral agents are expected to become standard of care for stroke prevention in atrial fibrillation patients, injectable agents will likely maintain their hold on certain hospital-based critical care applications. This research service covers the U.S. anticoagulant market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers and restraints are identified and assessed.

Table of Contents

Market Overview 10

Total Anticoagulant Market -

External Challenges: Drivers and Restraints 20

Forecasts and Trends 31

Demand Analysis 45

Market Share and Competitive Analysis 49

Parenteral Anticoagulant Segment Breakdown 61

Oral Anticoagulant Segment Breakdown 72

The Last Word (Conclusions and Implications) 83

Appendix 84

Relevant KOL Commentary 88